Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis

Clinical trial NCT06982352 · RECRUITING

Trial details

NCT number: NCT06982352
Sponsor: LAPIX Therapeutics Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Atopic Dermatitis (AD)Psoriasis (PsO)

Start date: 2025-06-15
Primary completion: 2026-01-15
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.